Skip to main content
. 2019 Aug 6;293(1):15–29. doi: 10.1148/radiol.2019190173

Table 3:

Studies of Tumor Size and Volume for Lung Cancer Outcome

graphic file with name radiol.2019190173.tbl3.jpg

Note.—ALK = anaplastic lymphoma kinase, CR = complete response, EGFR = epidermal growth factor receptor, HR = hazard ratio, NSCLC = non–small cell lung cancer, OS = overall survival, PFS = progression-free survival, PR = partial response, RECIST = Response Evaluation Criteria in Solid Tumors, SD = Stable Disease.

*As a continuous variable without cutpoint; correlation with PFS assessed by the scatter plot.